Announcement: Conference Cancellation

We regret to inform you that the upcoming MDR & IVDR Conference has been cancelled.

Reason: Despite our best efforts and a strong lineup of speakers, we’ve observed lower than anticipated attendance. This trend aligns with the current market response to events of this nature, influenced by recent postponements announced by the EU Commission.

Refunds: All registered attendees will receive a full refund. The process will commence shortly, and we appreciate your patience as we work through each transaction.

Additional Arrangements: We understand the importance of the insights and knowledge we intended to share. As such, we are exploring options such as a virtual event or providing recordings with handouts.

We deeply appreciate your understanding and support during this time. For any inquiries or further details, please contact our Marketing Manager, Mr. Peter Goossens, at

QbD Conference 2023

Join our brand-new three-day IVDR & MDR conference

About the IVDR & MDR conference

The QbD Group’s experts in Medical Devices (QbD) and In Vitro Diagnostics (Qarad) proudly present the first edition of their brand new QbD Conference.

Building on the successful Qarad IVDR Conferences of the past 6 years, we now offer next to the IVDR track an additional MDR track, under the new concept of the three-day QbD Group Conference.

Will you join us this year as well? Discover the program of your preferred track below and our beautiful new location Quartier Papier!

Previous slide
Next slide

What to expect?

Join us as we bring together international leaders, including speakers from renowned notified bodies, manufacturers, and our very own Qarad and QbD Group experts. Together, we will delve into the latest trends, challenges, and opportunities surrounding IVDs and MDs, focusing on hot topics such as software and artificial intelligence.
During this conference, we will address the implementation of the In Vitro Diagnostic Regulation (IVDR) and the Medical Device Regulation (MDR) throughout the entire device lifecycle. From idea to patient, we will explore the implications and best practices for successful compliance in Europe.

Stay ahead of the curve

The time to act is now! 

Unlike the overwhelming workload faced in 2022, Notified Bodies currently have significant availability. Don’t delay and wait for the rush when others start reaching out to them, potentially causing bottlenecks in the system.
Take the initiative and be proactive in planning your submissions for the second half of 2023 or the first half of 2024. By making this strategic move, you will gain a competitive edge and ensure a smoother transition to compliance.

Choose your industry track

Medical Devices

Patient safety is of paramount importance in the field of medical devices. To uphold high standards, the European Union has implemented the MD Regulation 2017/745  (MDR), which prioritizes the safety and efficacy of medical devices across their entire lifecycle.

Under the MDR, medical devices undergo rigorous assessments and must meet stringent requirements to ensure their compliance with safety standards.

The MDR places a strong emphasis on the documentation and clinical evaluation of medical devices. Manufacturers are required to provide comprehensive documentation of the device’s design, development, and manufacturing processes. Additionally, they must provide robust clinical evidence to demonstrate the device’s safety and effectiveness.

At the QbD Group, we have the in-depth knowledge and expertise necessary to assist manufacturers, distributors, and importers of medical devices in ensuring compliance with legislative requirements throughout the entire lifecycle of a medical device.

In Vitro Diagnostics

In today’s ever-evolving landscape of medical diagnostics, the field of in vitro diagnostics (IVD) is undergoing a rapid and transformative evolution. Propelled by groundbreaking technological advancements and a deeper understanding of medical science, the IVD industry is experiencing a remarkable journey of progress.

A pivotal milestone in this journey occurred in 2017 when the European Union unveiled the IVD Regulation 2017/746 (IVDR), a landmark legislation that set new benchmarks for regulatory requirements. This regulatory shift necessitates a high level of expertise and ample resources to navigate the complex landscape and ensure a swift time-to-market for IVD innovations.

At Qarad (part of the QbD Group), we understand the challenges inherent in this dynamic regulatory environment. Equipped with extensive experience and comprehensive knowledge, we stand ready to assist your company in overcoming all your regulatory hurdles.



Be sure to book in time, because seats are limited! Right now, we are offering an exclusive early bird discount of 20% if you register before July 31. Simply use the code QBDEARLY23 during checkout (below).